Vivid Wealth Management LLC Has $2.32 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Vivid Wealth Management LLC reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 45.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,895 shares of the biotechnology company’s stock after selling 3,259 shares during the quarter. Vivid Wealth Management LLC’s holdings in Axon Enterprise were worth $2,315,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Vontobel Holding Ltd. increased its stake in Axon Enterprise by 58.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 4,066 shares of the biotechnology company’s stock worth $1,625,000 after acquiring an additional 1,503 shares during the last quarter. SPC Financial Inc. lifted its holdings in Axon Enterprise by 2.2% in the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock worth $708,000 after buying an additional 38 shares during the period. Bleakley Financial Group LLC lifted its stake in shares of Axon Enterprise by 7.9% in the 3rd quarter. Bleakley Financial Group LLC now owns 1,507 shares of the biotechnology company’s stock valued at $602,000 after purchasing an additional 110 shares during the period. Teamwork Financial Advisors LLC increased its position in Axon Enterprise by 39.6% during the 3rd quarter. Teamwork Financial Advisors LLC now owns 10,672 shares of the biotechnology company’s stock valued at $4,265,000 after buying an additional 3,025 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in shares of Axon Enterprise by 2.0% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 7,391 shares of the biotechnology company’s stock worth $2,953,000 after purchasing an additional 143 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is owned by insiders.

Analysts Set New Price Targets

AXON has been the topic of several research analyst reports. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Stock Up 2.8 %

AXON stock opened at $683.41 on Friday. The company’s 50 day simple moving average is $623.22 and its 200-day simple moving average is $506.30. The firm has a market capitalization of $52.11 billion, a PE ratio of 176.59, a P/E/G ratio of 6.79 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $260.27 and a 12 month high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.